These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2051152)

  • 21. [Treatment of post-traumatic stress syndrome].
    Lepine JP; Darves-Bornoz JM
    Acta Psychiatr Belg; 1993; 93(3):121-35. PubMed ID: 8030427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind study of imipramine versus phenelzine in Melancholias and Dysthymic Disorders.
    Vallejo J; Gasto C; Catalan R; Salamero M
    Br J Psychiatry; 1987 Nov; 151():639-42. PubMed ID: 3446308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of symptoms of atypical depression for differential drug treatment outcome.
    McGrath PJ; Stewart JW; Harrison WM; Ocepek-Welikson K; Rabkin JG; Nunes EN; Wager SG; Tricamo E; Quitkin FM; Klein DF
    J Clin Psychopharmacol; 1992 Jun; 12(3):197-202. PubMed ID: 1629387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    Am J Psychiatry; 1993 Dec; 150(12):1843-8. PubMed ID: 8238640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine in posttraumatic stress disorder.
    van der Kolk BA; Dreyfuss D; Michaels M; Shera D; Berkowitz R; Fisler R; Saxe G
    J Clin Psychiatry; 1994 Dec; 55(12):517-22. PubMed ID: 7814344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
    Versiani M; Nardi AE; Mundim FD; Alves AB; Liebowitz MR; Amrein R
    Br J Psychiatry; 1992 Sep; 161():353-60. PubMed ID: 1393304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of rating scales completed by psychiatrists, nurses and patients to antidepressant drug effects.
    Raskin A; Crook TH
    J Psychiatr Res; 1976; 13(1):31-41. PubMed ID: 966189
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.
    Sheehan DV; Ballenger J; Jacobsen G
    Arch Gen Psychiatry; 1980 Jan; 37(1):51-9. PubMed ID: 7352840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of premenstrual dysphoric symptoms in depressed women.
    Glick R; Harrison W; Endicott J; McGrath P; Quitkin FM
    J Am Med Womens Assoc (1972); 1991; 46(6):182-5. PubMed ID: 1744374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 37. Predicting response to amitriptyline in posttraumatic stress disorder.
    Davidson JR; Kudler HS; Saunders WB; Erickson L; Smith RD; Stein RM; Lipper S; Hammett EB; Mahorney SL; Cavenar JO
    Am J Psychiatry; 1993 Jul; 150(7):1024-9. PubMed ID: 8317571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
    Rabkin JG; Markowitz JS; Stewart J; McGrath P; Harrison W; Quitkin FM; Klein DF
    Psychiatry Res; 1986 Sep; 19(1):75-86. PubMed ID: 3538107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.
    Davidson JR; Weisler RH; Butterfield MI; Casat CD; Connor KM; Barnett S; van Meter S
    Biol Psychiatry; 2003 Jan; 53(2):188-91. PubMed ID: 12547477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.